Meeting Banner
Abstract #1714

Molecular Imaging-Based Pancreatic Cancer Characterization

Marie-France Penet1, Paul T. Winnard Jr. 1, Flonn Wildes1, Yelena Mironchik1, Tariq Shah1, Anirban Maitra2, Zaver M. Bhujwalla3

1JHU ICMIC Program Division of Cancer Imaging Research The Russell H. Morgan Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; 2Departments of Pathology and Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States; 3JHU ICMIC Program Division of Cancer Imaging Research The Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, MD, United States

Pancreatic cancer is a very aggressive and lethal neoplasm that often induces cachexia and is typically detected at an advanced stage. Better understanding of the disease, early detection, and new therapeutic targets are urgently needed. Using mouse xenograft models, we have investigated the metabolism of multiple pancreatic tumors, and their effect on body weight. High total choline was observed in tumors that induced significant weight loss in tumor-bearing mice. To understand the interactions between the tumor and normal tissue, we are developing a cell-based optical biosensor using genetically engineered myoblasts to detect the early onset of cachexia-inducing signals.

Abstract PDF

Keywords

acquisition advanced aggressive aims already amongst analyses analyzed anorexia antibodies apparent approximately await basic becomes better body cancer cause cell cells characterization characterize characterized chemiluminescent choline clamped cocktail concentrations conditioned constitutive control correlation critically culture death deaths detect detection devastating developed developing differentiated disease distant domain driving dual engineered excised exhibited expression extracts fluorescence fluoride free freeze fused genetically going highest human identification identify important improve in vivo include induced inducible inducing inflammation initial inoculated invades inverse jaundice johns known lactate lipid loss major male markers measured mediator medicine medium membranes metabolite metabolites metastasis metastasizes mice minimal molecular mouse muscle needed normalized obstruction often optical organs originally outcome pancreatic patients patterns post potential presence promoter protease protein proteins radiology reached repeat repetition resolution rest school severe shah significantly silent sodium software spectra supported surrounding sweep symptoms syndrome systems tandem targets therapeutic transients tumor tumors type understanding undifferentiated visible water weeks west western year